← Evidence map

ArticlePloS one2015

Correction: Circulating miR-19a and miR-205 in Serum May Predict the Sensitivity of Luminal A Subtype of Breast Cancer Patients to Neoadjuvant Chemotherapy with Epirubicin Plus Paclitaxel.

Qian Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2015
2016
2017
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 26305791